The introduction of a 750mcg teriparatide injection in the nation has recently impacted treatment options for individuals with severe bone loss . As of now , this higher dosage product is available through limited physicians and medical centers throughout Australia, following strict therapeutic guidelines. Revenue figures for the 750mcg injection r